Viewing nowDapaolone Tablet 10 mg (Dapagliflozin bis L-Proline)
Dapagliflozin Bis L-proline 15.6mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202003735 · Approved 2020.05.22 · Insurance code 643508270
Improvement of glycemic control in type 2 diabetes; prevention of worsening chronic heart failure and chronic kidney disease
This medication is used in conjunction with diet and exercise to assist in blood sugar control for patients with type 2 diabetes. It also reduces the risk of hospitalization and emergency visits due to heart failure in patients with chronic heart failure, and lowers the risk of death from cardiovascular disease. In patients with chronic kidney disease, it is used to lower risks associated with declining kidney function and reduce the risk of death from cardiovascular disease. This medication helps improve major health issues in patients with type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR below 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no relevant data.
This medication should not be used in patients who have had allergic reactions to the active ingredient or any excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance or specific genetic issues should not receive this medication due to the lactose content. It should also not be used in patients undergoing dialysis. Patients with reduced fluid volume or kidney function issues should use this medication with caution. This medication can lower blood pressure and reduce blood volume, which can cause symptomatic hypotension or worsen kidney function. Particularly, elderly patients with reduced kidney function or those taking diuretics should be more cautious, and kidney function and blood pressure should be monitored before and during administration. This medication is not recommended for patients with very low kidney function. Taking this medication may commonly lead to genital infections; if related symptoms occur, immediate treatment is necessary. Symptoms of hypoglycemia may appear, especially when taken in conjunction with insulin or sulfonylureas, increasing the risk. Due to reduced fluid volume, dehydration or hypotension may occur, so hydration status should be carefully managed. Diabetic ketoacidosis, a serious metabolic anomaly, may rarely occur; if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing arise, immediate consultation with healthcare professionals is required. Urinary tract infections may also commonly occur, and rapid treatment is necessary if symptoms are present. As kidney function-related adverse reactions, creatinine levels may temporarily rise, so regular testing is needed. Very rarely, severe infections in the perineal area may occur; if there is pain, swelling, or fever in that area, healthcare professionals should be informed immediately. Patients with poor liver function or the elderly should use this medication with extra caution. Patients at risk of reduced fluid volume should closely monitor hydration status and blood pressure, and medication may be temporarily suspended if necessary. This medication increases urination, which may affect patients with bladder disorders, so caution is advised. Pregnant women or nursing mothers should refrain from using this medication, and if pregnancy is confirmed, it should be discontinued immediately. Safety and efficacy in pediatric patients have not yet been established. This medication may increase the risk of hypoglycemia when used with insulin or sulfonylureas, so adjustments of doses for these medications may be necessary. In case of overdose, there is no specific antidote, and symptomatic treatment should be provided, as it is not removed by dialysis. Lastly, during the use of this medication, caution should be exercised regarding the symptoms of hypoglycemia while driving or operating machinery. The medication should be kept out of the reach of children and stored in its original container.
Vulvovaginitis, balanitis, and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbago, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased creatinine clearance in the early stages of treatment, dyslipidemia, elevated blood creatinine in the early stages of treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, gastroesophageal reflux disease, upper abdominal pain, diverticulitis, intestinal perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, taste distortion, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Storing it this way ensures the safety of the medication's efficacy.
Yellow, double convex, diamond-shaped film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Bis L-proline 15.6mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 7.8mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Boryung Pharm. Co., Ltd.
Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 7.815mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 7.815mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.